Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Update on ocular allergy treatment.

Leonard Bielory1

  • 1UMDNJ - Asthma & Allergy Research Center, Department of Medicine, Pediatrics and Ophthalmology, New Jersey Medical School, Newark, New Jersey 07103, USA. bielory@umdnj.edu

Expert Opinion on Pharmacotherapy
|May 9, 2002
PubMed
Summary

Allergic conjunctivitis, a common eye allergy, affects millions globally. Newer multi-acting topical medications offer improved relief and treatment options beyond traditional methods.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Unraveling the immune-microbial axis in chronic ocular surface disease.

Current opinion in allergy and clinical immunology·2025
Same author

Bridging diagnostic gaps in anterior ocular inflammatory surface diseases.

Current opinion in allergy and clinical immunology·2025
Same author

From innovation to implementation: strengthening anterior ocular inflammatory surface diseases diagnostics through global health policy.

Current opinion in allergy and clinical immunology·2025
Same author

The Link Between Allergic Rhinitis and Keratoconus: A Call for Greater Awareness, Early Intervention, and Future Ocular Surface Diagnostic Tools.

The journal of allergy and clinical immunology. In practice·2024
Same author

The collaborative medical practice of the ocular surface: a major role of the allergist/immunologist.

Current opinion in allergy and clinical immunology·2024
Same author

Ocular surface disorders: office procedures for the allergist/clinical immunologist.

Current opinion in allergy and clinical immunology·2024

Area of Science:

  • Ophthalmology
  • Allergology
  • Pharmacology

Background:

  • Allergies impact over 15% of the global population, with ocular allergies being a prominent and disabling feature.
  • Allergic conjunctivitis costs the US billions annually, with significant expenditure on medications.
  • Ocular prescription medication costs have surged, driven by advanced multi-acting topical treatments.

Purpose of the Study:

  • To review the current landscape of ocular allergy treatment.
  • To highlight the benefits of newer multi-acting topical medications.
  • To discuss the evolving treatment paradigm for allergic conjunctivitis.

Main Methods:

  • Review of current literature on allergic conjunctivitis and its treatment.
  • Analysis of healthcare costs and medication expenditures.
  • Discussion of treatment strategies from primary to tertiary measures.

Main Results:

  • Newer topical medications provide immediate relief and target late-phase reactions without steroid side effects.
  • The treatment paradigm includes avoidance, topical agents, steroids, and immunotherapy.
  • Advancements in therapies and delivery systems are expected to improve patient outcomes.

Conclusions:

  • Ocular allergy is a significant health issue with rising treatment costs.
  • Novel multi-acting topical agents represent a significant advancement in managing allergic conjunctivitis.
  • Continued innovation in therapies and delivery systems promises better healthcare outcomes.

Related Experiment Videos